Launch of PRECISESADS in Spain – El Pais Interview
Dr. Marta Alarcón gave an interview to the Spanish national newspaper el Pais describing PRECISESADS and it`s expected impact on society.
Leave a reply →Dr. Marta Alarcón gave an interview to the Spanish national newspaper el Pais describing PRECISESADS and it`s expected impact on society.
Leave a reply →Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
by phone: +34 958 715 500
by e-mail:
or fill in the form on contact page
This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.
PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
[…] Lanzamiento de PRECISESADS en España. […]
Reply →